You are viewing: Japan Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The Japan Compounding Pharmacy Market was valued at $189.9 Million in 2025 and projected to reach to $244.7 Million by 2030, representing a compound annual growth rate of 5.2%. Japan's compounding pharmacy market is positioned for steady growth through 2030, supported by demographic shifts and healthcare system modernization.

Japan Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Compounding Pharmacy Market Trends and Insights

  • Japan's aging population and increasing demand for personalized medication solutions are driving market expansion.
  • The compounding pharmacy sector in Japan benefits from regulatory support and growing healthcare provider adoption of customized pharmaceutical preparations. In Japan, the compounding pharmacy market is characterized by rising patient preference for tailored dosage forms and strengths that address specific clinical needs.
  • Between 2025 and 2030, Japan is expected to see accelerated growth driven by advances in pharmaceutical compounding technology and expanded reimbursement coverage.
  • Japan's healthcare system increasingly recognizes the clinical and economic value of compounded medications, positioning the country as a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2025-2030) 5.2% CAGR
  • Market Size, 2025 ~USD 189.9 Million
  • Forecast, 2030 ~USD 244.7 Million
  • Country Japan

Japan Compounding Pharmacy Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing demand for personalized medication solutions and customized compounding pharmacy services tailored to elderly patient needs.

Regulatory Support & Healthcare Integration :

Japanese regulatory bodies have implemented supportive policies for compounding pharmacies, facilitating integration with the national healthcare system and encouraging adoption of personalized medicine approaches across hospitals and clinics.

Market Valuation & Growth Trajectory :

Japan's compounding pharmacy market is valued at USD 189.9 million in 2025, with projected growth to USD 244.7 million by 2030, representing a steady CAGR of 5.2% driven by healthcare modernization.

Personalized Medicine Adoption :

Growing healthcare provider recognition of personalized medication benefits is accelerating compounding pharmacy adoption across Japan's urban and rural healthcare facilities, supporting market expansion.

Japan Compounding Pharmacy Market Dynamics

  • The aging population's complex medication requirements are creating sustained demand for customized pharmaceutical solutions, while regulatory frameworks continue to evolve favorably for compounding services.
  • Healthcare providers increasingly recognize the clinical and economic benefits of personalized medications in managing chronic diseases prevalent among elderly patients. The market outlook remains positive as Japanese healthcare institutions invest in compounding infrastructure and training.
  • Integration with digital health platforms and increased collaboration between compounding pharmacies and hospitals are expected to drive market penetration.
  • By 2030, compounding pharmacies will play a more prominent role in Japan's personalized medicine ecosystem, supported by continued government healthcare investment and aging population dynamics..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Japan's compounding pharmacy market is valued at USD 189.9 million in 2025 and is forecast to reach USD 244.7 million by 2030.
    • Japan is experiencing a 5.2% CAGR, driven by an aging population and demand for personalized medication solutions.
    • Japan's regulatory environment and healthcare system support the adoption of customized pharmaceutical preparations.
    • Japan's market growth is fueled by technological advances and expanded reimbursement coverage for compounded medications.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    Japan Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    JAPAN: COMPOUNDING PHARMACY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ADULTS269.2298.6324.4346.5364.9380.6397.2415.85.1
    GERIATRIC PATIENTS120.3132.4142.8151.4158.2163.8169.6176.24.3
    PEDIATRIC PATIENTS76.986.595.2103.1110.1116.3123130.56.5
    TOTAL466.3517.5562.4601633.2660.7689.9722.65.1

    Target Audience

    • Pharmaceutical Companies & Manufacturers : Need market intelligence on Japan's compounding pharmacy sector to identify partnership opportunities, develop localized product strategies, and understand regulatory requirements for market entry and expansion.
    • Healthcare Investors & Private Equity : Require detailed market sizing, growth projections, and competitive analysis to evaluate investment opportunities in Japan's compounding pharmacy market and assess portfolio company potential.
    • Compounding Pharmacy Operators : Need Japan-specific market data to benchmark performance, identify growth opportunities, understand competitive positioning, and develop expansion strategies within the Japanese healthcare system.
    • Healthcare Consultants & Strategy Firms : Require comprehensive market insights to advise clients on Japan's compounding pharmacy landscape, regulatory environment, and strategic opportunities for healthcare organizations and pharmaceutical companies.
    • Hospital & Healthcare System Administrators : Need market intelligence on compounding pharmacy services to evaluate integration opportunities, understand patient demand trends, and make informed decisions about in-house or outsourced compounding capabilities.

    Key Companies in the Japan Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Demographic Opportunity Assessment : Understand how Japan's aging population structure creates specific market opportunities for compounding pharmacy services and identify high-potential customer segments within the elderly demographic.
    • Regulatory Landscape Intelligence : Gain detailed insights into Japan's supportive regulatory environment for compounding pharmacies, including compliance requirements, licensing pathways, and government healthcare policies affecting market entry and expansion.
    • Competitive Market Positioning : Analyze Japan's compounding pharmacy competitive landscape, identify key market players, assess market share distribution, and develop strategies for differentiation in this growing sector.
    • Growth Forecasting & Investment Planning : Access precise market valuation data (USD 189.9M in 2025 to USD 244.7M in 2030) and 5.2% CAGR projections to inform investment decisions, business planning, and resource allocation for Japan operations.
    • Healthcare Integration Strategies : Discover how compounding pharmacies are integrating with Japan's hospital systems and healthcare networks, enabling informed partnership development and market penetration strategies specific to Japanese healthcare infrastructure.

    Frequently asked questions

    What is the current size of Japan's compounding pharmacy market?

    Japan's compounding pharmacy market is valued at USD 189.9 million in 2025.

    What is the projected market size for Japan's compounding pharmacy sector by 2030?

    Japan's compounding pharmacy market is projected to reach USD 244.7 million by 2030.

    What is the CAGR for Japan's compounding pharmacy market?

    Japan's compounding pharmacy market is growing at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2030.

    What factors are driving growth in Japan's compounding pharmacy market?

    Japan's market growth is driven by an aging population, increasing demand for personalized medications, regulatory support, technological advances, and expanded reimbursement coverage.

    How does Japan's compounding pharmacy market compare to other Asia Pacific countries?

    Japan is positioned as a key growth market within the Asia Pacific region, with strong regulatory support and healthcare system adoption of customized pharmaceutical preparations.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status